InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Milne Jill C.. Director active across 2 companies, notably Biocryst Pharmaceuticals INC. Cumulatively, 6 disclosures have been recorded. Activity tracked since 23 January 2026. The latest transaction was filed on 29 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Milne Jill C. is a declarant linked to Biocryst Pharmaceuticals INC, where she is Director, and to Astria Therapeutics, Inc., where she is CEO and President. She has 6 filings in total, and the 6 sampled filings cover the period from 2026-01-23 to 2026-06-15, with transactions whose stated nature is Attribution.